Beck Depression Inventory (BDI); higher score means more depression · people with ESKD
Exercise showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Cognitive‐behavioural therapy showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Relaxation techniques showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (moderate certainty).
1 finding from 1 review
Beck Depression Inventory (BDI); higher score means more depression · people with ESKD
It is very uncertain whether spiritual practice changes depression (any severity, including mild, moderate and severe… compared with usual care (very low certainty).
1 finding from 1 review
Depressive symptoms · people with ESKD
Counselling showed no clear difference in depression (any severity, including mild, moderate and severe… compared with usual care (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with neovascular age‐related macular degeneration
Summary of findings: anti‐VEGF treatment probably leads to higher gain of 15 or more letters visual acuity at 1 year compared with control (moderate certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with neovascular age‐related macular degeneration
Summary of findings: bevacizumab showed no clear difference in gain of 15 or more letters visual acuity at 1 year compared with ranibizumab (high certainty).
1 finding from 1 review
Intervention not reported
Infusion‐related reactions (number of participants with one or more reaction) · adults and children with mucopolysaccharidosis I
The intervention showed no clear difference in infusion‐related reactions (number of participants with one or more… (low certainty).
1 finding from 1 review
Objective cure rates in the longer‐term ‐ more than 12 months, · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective cure rates in the longer‐term ‐ more than 12 months, · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective cure rates in the longer‐term ‐ more than 12 months, · women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number experiencing adverse effects · patients between 3 to 15 months of age with West syndrome
It is very uncertain whether sulthiame add‐on changes adverse effects: total number of participants experiencing one or… compared with placebo (very low certainty).
1 finding from 1 review
Any pain‐related outcome indicating some improvement · adults with neuropathic pain
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with oral omega‐6 PUFAs (low certainty).
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Aqueous tear production · people with dry eyea
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in schirmer test (aqueous tear production, measured in mm/5 min, with… compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Achievement of at least 50% reduction in headache severity Post‐treatment Higher scores indicate more children with reduced headache · children or adolescents with headaches
It is very uncertain whether the intervention changes achievement of at least 50% reduction in headache severity… (very low certainty).
1 finding from 1 review
Pain at 6 months or more; all doses Assessed by change from baseline, using a 0‐ to 100‐mm VAS, where higher scores indicate more pain) · people with diabetic peripheral neuropathy
1 finding from 1 review
Impairment of sensation Assessed by quantitative sensory testing ‐ thermal threshold ‐ at 6 months or more · the treatment of diabetic peripheral neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptom quality and severity Assessed by NSS score (range of possible scores 0 to 9; higher scores indicate more symptoms) · the treatment of diabetic peripheral neuropathy
1 finding from 1 review